Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Nursing | Pediatrics | Pharmacy | Psychiatry | Journal

Back to Journal Articles

Antipsychotic Use Up Among U.S. Medicaid-Enrolled Youth

Last Updated: September 14, 2012.

 

By 2007, youth with ADHD accounted for half of total antipsychotic use

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

FRIDAY, Sept. 14 (HealthDay News) -- There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder (ADHD) and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

Meredith Matone, M.H.S., from the Children's Hospital of Philadelphia, and colleagues used Medicaid Analytic Extract files for 50 states and the District of Columbia to describe the relationship between mental health diagnosis and treatment with antipsychotics in children from 2002 to 2007.

The researchers found that there was a 62 percent increase in antipsychotic use, reaching 354,000 youth by 2007. Proportionally, youth with bipolar disorder, schizophrenia, and autism were more likely to receive antipsychotics, while the largest consumers of antipsychotics over time were youth with ADHD and those with three or more mental health diagnoses. By 2007, 50 percent of total antipsychotic use was for youth with ADHD and one in seven antipsychotic users were youth with a sole diagnosis of ADHD.

"This national analysis revealed persistent growth in second-generation antipsychotic use among U.S. Medicaid-enrolled children during the past decade," the authors write. "In the context of a complex relationship between childhood behavior, diagnosis, and treatment, future research will need to more broadly examine the efficacy and safety of second-generation antipsychotic use in pediatric populations and the potential consequences of efforts to restrict their use."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: 'Choosing Wisely' Suggestions Should Improve Kidney Care Next: Risk of Car Accidents Up With Antidepressant Use

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.